Advertisement
Advertisement
-
Business /

Markets

Related Topics:
Made in China 2025

China biotech outlicensing tops US$52 billion in first 2 months

The latest deals are Sino Biopharmaceutical’s partnership with France’s Sanofi and Antengene’s agreement with Belgium’s UCB.

Asian tech stocks reel as US-Iran war threatens infrastructure and supply chains

Surging oil prices drive Hong Kong stocks to 3-month low on inflation jitters

Brent crude gains 1.3 per cent to US$82.46, while Nymex futures rise 1.1 per cent to US$75.36.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW